David W. Boyer sold $422K of Neurocrine Biosciences (NBIX)

Executed Sep 13 2024, disclosed Sep 17 2024, 4 days later.

Value, as filed

$422K

3,461 sh × $121.88

Executed

Sep 13 2024

the trade date, as filed

Disclosed

Sep 17 2024

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

DB David W. Boyer Chief Corp. Affairs Officer profile →

David W. Boyer (Chief Corp. Affairs Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Neurocrine Biosciences, Inc. (NBIX). The largest single filing was $609K of NBIX (3,888 sh × $156.64, as filed), executed May 26.

The name

NBIX Neurocrine Biosciences, Inc. NBIX · Healthcare · 59 filings in 24 months ticker →

Healthcare · Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunolog…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by David W. Boyer in NBIX

NBIXSALE Neurocrine Biosciences, Inc. $130K
826 sh × $157.45
Exec Sep 14
Filed Sep 15 · 5:03 PM ET NBIXSALE Neurocrine Biosciences, Inc. $609K
3,888 sh × $156.64
Exec May 26
Filed May 28 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. $112K
955 sh × $116.79
Exec Feb 13 2025
Filed Feb 14 2025 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. $169K
1,104 sh × $152.94
Exec Jan 31 2025
Filed Feb 4 2025 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. $147K
1,295 sh × $113.66
Exec Oct 3 2024
Filed Oct 7 2024 · 5:30 PM ET